Evaluation of the effect of TauroLock™ and piperacillin-tazobactam in secondary prophylaxis of Port-Catheter infection.
Phase 3
Recruiting
- Conditions
- Infection due to port catheter.Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
- Registration Number
- IRCT20180309039013N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Having Port-Catheter
Age between 0-19
Having cancer
Exclusion Criteria
Critically ill patients
Patients with severe coagulation problems
No permission from child's parents
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of infection of systemic bloodstream incidence due to port infection. Timepoint: Before the beginning of the intervention, once a day during the intervention, and at the end of the intervention. Method of measurement: Positive blood culture according to standard microbiological process.
- Secondary Outcome Measures
Name Time Method Port survival rate (No need to exit port or reload). Timepoint: Once a day during the intervention, and at the end of the intervention. Method of measurement: I will record the change of port by observation.